Scale with Laerdal in the US Healthtech market

Through Laerdal’s “enabling platform”, participants gain:

• Access to clinical networks and insights into US hospital systems
• Support for market entry, regulatory readiness, and commercial validation
• Opportunities for pilot projects and co-creation with US hospitals

• The US is the largest market for health technology globally
• Dominated by private hospitals and insurers, offering faster, less bureaucratic sales processes than Europe
• Home to world-leading hospital systems, perfect for testing and scaling innovations

Phase 1 – Selection & Market Match
Identify needs in the US health sector and select 4–6 Norwegian companies with genuine market potential, using insights from Laerdal and hospital partners.

Phase 2 – Validation & Gap Analysis
Assess readiness for the US market: regulatory, commercial, product, financial and operational dimensions.

Phase 3 – Clinical Partnership & Scaling
Real-world validation through pilot projects, co-creation, funding support, and preparation for EHR integration.

Phase 4 – Market Acceleration
Enable rapid market penetration via Laerdal’s networks, client access, and scaling strategies.

• Direct access to leading US health institutions and expert networks
• Practical guidance on market entry, clinical validation, and operational readiness
• Opportunities for pilot projects and co-creation to prove product-market fit

This program positions Norwegian healthtech companies to expand internationally with confidence, using Laerdal’s expertise and strategic US partnerships as a springboard.